Company Filing History:
Years Active: 2007-2012
Title: Innovations by Jennifer Marugg in Cognitive Disorder Treatments
Introduction
Jennifer Marugg is a notable inventor based in San Jose, California, recognized for her contributions to the field of cognitive disorder treatments. With a total of five patents to her name, she has made significant strides in developing pharmaceutical compositions aimed at addressing conditions such as Alzheimer's Disease.
Latest Patents
Among her latest patents are N-substituted benzene sulfonamides, which are designed for use in treating or preventing cognitive disorders. These compounds, defined by specific formulas, offer potential therapeutic benefits for individuals suffering from Alzheimer's Disease. The invention encompasses not only the compounds themselves but also pharmaceutical compositions and methods for treating cognitive disorders using these innovative compounds.
Career Highlights
Jennifer Marugg has established herself as a key figure in the pharmaceutical industry, particularly through her work at Elan Pharmaceuticals, Inc. Her research and inventions have contributed to advancements in the treatment of cognitive disorders, showcasing her dedication to improving patient outcomes.
Collaborations
Throughout her career, Jennifer has collaborated with esteemed colleagues, including Martin Neitzel and Jay S Tung. These partnerships have further enhanced her research efforts and innovation in the field.
Conclusion
Jennifer Marugg's work exemplifies the impact of innovation in the treatment of cognitive disorders. Her patents and collaborations reflect a commitment to advancing medical science and improving the lives of those affected by such conditions.